Picture of Equillium logo

EQ — Equillium News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Equillium Inc expected to post a loss of 31 cents a share - Earnings Preview

* Equillium Inc  EQ.OQ   EQ.O  is expected to show a no change
in quarterly revenue when it reports results on August 10
(estimated). 
​* Refinitiv's mean analyst estimate for Equillium Inc is for a
loss of 31 cents per share. For the same quarter last year, the
company reported a loss of 37 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Equillium Inc
is $13​, about 53.5% above​ its last closing price of $6.05. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.33       -0.32      -0.33     Missed  -2.5
 Dec. 31 2020  -0.37       -0.40      -0.36     Beat    10.4
 Sep. 30 2020  -0.42       -0.40      -0.31     Beat    22​
 Jun. 30 2020  -0.45       -0.45      -0.37     Beat    17.8
 Mar.          -0.43​      -0.42      -0.45     Missed  -7.8​
 31​ 2020​                                              
 Dec. 31 2019  -0.41       -0.39      -0.44     Missed  -13.5​
 Sep. 30 2019  -0.39       -0.40      -0.35     Beat    11.8
 Jun. 30 2019  -0.39       -0.34      -0.35     Missed  -2.2
 This summary was machine generated August 6 at 15:46 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Equillium

See all news